cyclopentane has been researched along with topotecan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubry, A; Avet-Loiseau, H; Bremner, R; Charish, J; Corre, J; Monnier, PP; Pearson, JD; Sivak, JM; Xirodimas, DP; Yu, T | 1 |
1 other study(ies) available for cyclopentane and topotecan
| Article | Year |
|---|---|
Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cyclopentanes; NEDD8 Protein; Ribosomal Proteins; Topotecan; Tumor Suppressor Protein p53 | 2023 |